Can-Fite BioPharma Ltd.
CANF · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $12 | $17 | $14 | $17 |
| - Cash | $6 | $6 | $5 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $6 | $10 | $9 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | -43.6% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | -2,413.4% | -2,413.4% | -1,125.7% | -1,125.7% |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -2,413.9% | -2,413.9% | -1,095.5% | -1,095.5% |
| EPS Diluted | -0.21 | -0.21 | -0.24 | -0.24 |
| % Growth | 0% | 12.5% | 0% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$2 |